Literature DB >> 3398173

Use of the gastroduodenal artery in right renal artery revascularization.

A C Moncure1, D C Brewster, R C Darling, W M Abbott, R P Cambria.   

Abstract

Of 15 patients having revascularization of the right renal artery with the use of the hepatic circulation from May 1984 through March 1987 at the Massachusetts General Hospital, eight patients had this accomplished with end-to-end anastomosis of the gastroduodenal artery and right renal artery. Operative indications were acute azotemic renal failure (three patients), poorly controlled renovascular hypertension (four patients), and staged repair of bilateral renal artery disease (one patient). All revascularizations were successful in restoring renal function or rendering hypertension manageable and were assessed by means of renal flow scans, celiac angiography, or return of function in those patients with a solitary, functioning kidney. All patients survived the operation with one late death caused by myocardial infarction after abdominal aortic aneurysm repair. The gastroduodenal artery may be used as the source for arterial inflow in revascularization of the right renal artery by end-to-end anastomosis in approximately 50% of instances, conferring the advantage of the use of only one anastomosis and obviating the long-term possibility of vein graft failure.

Entities:  

Mesh:

Year:  1988        PMID: 3398173

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

1.  Ascending aorta-abdominal aorta bypass with the reconstruction of superior mesenteric and bilateral renal arteries for mid-aortic syndrome.

Authors:  Mitsuaki Matsumoto; Kotaro Suehiro; Hiroshi Kubo
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-12

2.  Renal artery revascularization using the inferior mesenteric artery as an inflow source with a long-term follow-up.

Authors:  Khaled I Alnahhal; Tambi Jarmi; Albert G Hakaim; Houssam Farres
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.